Trial Profile
Phase I trial of Afatinib intercalated with Carboplatin/Pemetrexed Chemotherapy in advanced non-squamous non-small-cell lung cancer harboring EGFR mutations.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Afatinib (Primary) ; Carboplatin (Primary) ; Pemetrexed (Primary) ; Cobalamin; Folic acid
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 01 Aug 2018 Results published in the Anticancer Research
- 10 Nov 2017 Status changed from active, no longer recruiting to completed, according to results presented at the 18th World Conference on Lung Cancer.
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer.